Great Valley Advisor Group, Inc. Gilead Sciences, Inc. Transaction History

Great Valley Advisor Group, Inc.

$3.84 Billion
Q3 2024

A detailed history of Great Valley Advisor Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 5,563 shares of GILD stock, worth $501,726. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,563

Previous 5,994 7.19%

Holding current value

$501,726

Previous $411,000 13.38%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $28,700 - $36,199	-431 Reduced 7.19%	5,563 $466,000
Q2 2024 Jul 16, 2024	SELL	$63.15 - $72.88 $79,947 - $92,266	-1,266 Reduced 17.44%	5,994 $411,000
Q1 2024 May 03, 2024	SELL	$71.58 - $87.29 $31,137 - $37,971	-435 Reduced 5.65%	7,260 $531,000
Q4 2023 Feb 05, 2024	SELL	$73.27 - $83.09 $302,531 - $343,078	-4,129 Reduced 34.92%	7,695 $623,000
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $144,848 - $158,032	1,959 Added 19.86%	11,824 $886,000
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $18,090 - $20,634	238 Added 2.47%	9,865 $760,000
Q1 2023 May 02, 2023	BUY	$77.31 - $88.08 $203,557 - $231,914	2,633 Added 37.65%	9,627 $798,000
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $12,962 - $18,609	-208 Reduced 2.89%	6,994 $600,000
Q3 2022 Oct 21, 2022	SELL	$59.54 - $68.01 $10,657 - $12,173	-179 Reduced 2.43%	7,202 $444,000
Q2 2022 Jul 19, 2022	SELL	$57.72 - $65.01 $199,653 - $224,869	-3,459 Reduced 31.91%	7,381 $456,000
Q1 2022 Apr 20, 2022	SELL	$57.92 - $72.58 $20,793 - $26,056	-359 Reduced 3.21%	10,840 $648,000
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $778 - $883	12 Added 0.11%	11,199 $811,000
Q3 2021 Oct 14, 2021	SELL	$67.69 - $73.03 $41,493 - $44,767	-613 Reduced 5.19%	11,187 $781,000
Q2 2021 Jul 27, 2021	BUY	$63.47 - $69.35 $952 - $1,040	15 Added 0.13%	11,800 $810,000
Q1 2021 Apr 20, 2021	SELL	$60.0 - $68.46 $157,020 - $179,159	-2,617 Reduced 18.17%	11,785 $762,000
Q4 2020 Jan 29, 2021	SELL	$56.65 - $64.55 $2.42 Million - $2.76 Million	-42,790 Reduced 74.82%	14,402 $839,000
Q3 2020 Oct 21, 2020	BUY	$62.1 - $78.08 $30,863 - $38,805	497 Added 0.88%	57,192 $3.61 Million
Q2 2020 Jul 31, 2020	BUY	$72.34 - $84.0 $805,650 - $935,508	11,137 Added 24.45%	56,695 $4.36 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $2.01 Million - $2.57 Million	32,070 Added 237.77%	45,558 $3.41 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $45,044 - $49,547	-731 Reduced 5.14%	13,488 $877,000
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $96,640 - $106,674	1,546 Added 12.2%	14,219 $901,000
Q2 2019 Jul 30, 2019	BUY	$61.87 - $69.38 $31,058 - $34,828	502 Added 4.12%	12,673 $856,000
Q1 2019 Apr 26, 2019	SELL	$62.53 - $70.05 $253,621 - $284,122	-4,056 Reduced 25.0%	12,171 $791,000
Q4 2018 Apr 11, 2019	BUY	$60.54 - $79.0 $982,382 - $1.28 Million	16,227 New	16,227 $1.02 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.

Account

Great Valley Advisor Group, Inc. Gilead Sciences, Inc. Transaction History